Found 87 hits of Enzyme Inhibition Constant Data
TargetType-1 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at angiotensin 1 receptorMore data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Antagonist activity at neurokinin K1 receptorMore data for this Ligand-Target Pair
TargetType-1 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Antagonist activity at angiotensin 1 receptorMore data for this Ligand-Target Pair
TargetCathepsin S(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of cathepsin SMore data for this Ligand-Target Pair
TargetSubstance-P receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Antagonist activity at neurokinin K1 receptorMore data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetAngiotensin-converting enzyme(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetCathepsin S(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of cathepsin SMore data for this Ligand-Target Pair
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Antagonist activity at angiotensin 2 receptorMore data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetAngiotensin-converting enzyme(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 5.90nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at angiotensin 2 receptorMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 25nMAssay Description:Antagonist activity at angiotensin 2 receptorMore data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of human EGFR kinase activityMore data for this Ligand-Target Pair
TargetAngiotensin-converting enzyme(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 93nMAssay Description:Binding affinity to Bcl2 by fluorescent polarization assayMore data for this Ligand-Target Pair
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Antagonist activity at angiotensin 2 receptorMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Antagonist activity at angiotensin 2 receptorMore data for this Ligand-Target Pair
TargetProstaglandin G/H synthase 1(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of human EGFR kinase activityMore data for this Ligand-Target Pair
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Antagonist activity at angiotensin 2 receptorMore data for this Ligand-Target Pair
TargetCathepsin B(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of cathepsin BMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 275nMAssay Description:Antagonist activity at angiotensin 2 receptorMore data for this Ligand-Target Pair
TargetAldo-keto reductase family 1 member B1(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 390nMAssay Description:Inhibition of aldose reductaseMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetProstaglandin G/H synthase 2(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetProstaglandin G/H synthase 1(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of HER1More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of HER2More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.06E+3nMAssay Description:Inhibition of SERTMore data for this Ligand-Target Pair
TargetCoagulation factor X(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of MMP9More data for this Ligand-Target Pair